Loading clinical trials...

UNKNOWNNANCT06200662

Pain Relief in Premature Newborns Through Maternal Intervention During Venipuncture

Extremely premature newborn infants (ELNs) admitted to hospital are exposed to stressful and painful stimuli, and often to maternal separation, which can affect their long-term neurological developmen...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Elodie RABATEL, Nurse

CONTACT

+33 3 88 12 77 85 elodie.rabatel@chru-strasbourg.fr

Related studies

Active Not RecruitingNA

Skin-to-skin Contact During the Transfer From the Delivery Room to the Neonatal Intensive Care Unit: Impact on Very Preterm Infants and Their Parents

NCT05820386 · Skin to Skin, Premature Newborns

TERMINATEDNA

Odors to Insufflate Life

NCT02851979 · Premature Newborns With Gestational Age 28 to 33 Weeks

UNKNOWN

TDM of Gentamicin and Vancomycin, in Neonates, Using Dried Blood Spot Sampling.

NCT03651115 · Blood Sample for Routine Care, Term or Premature Newborns (28 to 44 Amenorrhea Weeks), and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 9, 2024Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment48

Start dateFeb 2024

Last updatedJul 9, 2024

Condition

Premature Newborns

Locations shown

Les Hôpitaux Universitaires

Strasbourg, Bas-Rhin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions